VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix, Inc. (PKTX) (OTCBB:PKTX) announces that a top tier company in Umbilical Cord Blood Preservation has conducted preliminary tests using AAGP™ as a protective agent in the cryofreezing (-196°C) and subsequent thawing of cord blood units. The results, using a relatively small number of samples of cord blood and a low concentration of AAGP™ (4mg/ml) showed a 104% average increase over the control group (cells not treated with AAGP™) in the yield following thawing.
